sublingual delivery glp-1 receptor agonists Schematic illustration of monoagonists, dual and triple Science's 2023 Breakthrough: GLP-1R Agonists
Description
Stiewig-Rapp is the incoming director of a new Obesity Clinic the health system is set to open in 2026
No operating room, no anesthesia, no endoscopy
Oral semaglutide likewise resulted in reductions in weight during the trial
Theres also a noted risk for thyroid cancer
